Metabolic control and satisfaction in a diabetes education programme in flash glucose monitoring through telemedicine in type 1 diabetes

Alva, 2020, Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes, J Diabetes Sci Technol, 16, 70, 10.1177/1932296820958754 Ang, 2020, Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life, J. Diabetes Complications, 34, 10.1016/j.jdiacomp.2020.107559 El Malahi, 2022, Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus, J Clin Endocrinol Metab, 107, e570, 10.1210/clinem/dgab688 Gomez-Peralta, 2020, Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain, BMJ Open Diabetes Res Care, 8, 10.1136/bmjdrc-2019-001052 Hermanns, 2019, The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: results of a randomized controlled trial, Diabetes Res Clin Pract, 150, 111, 10.1016/j.diabres.2019.03.003 Bolinder, 2016, Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial, Lancet, 388, 2254, 10.1016/S0140-6736(16)31535-5 Secretaría de Estado de Sanidad. Resol_Flash_2020.pdf. [En línea] [Accessed 1 September 2021]. Available from: https://www.mscbs.gob.es/profesionales/prestacionesSanitarias/CarteraDeServicios/ContenidoCS/docs/Resol_Flash_2020.pdf. Haak, 2017, Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial, Diabetes Ther, 8, 55, 10.1007/s13300-016-0223-6 Verhoeven, 2007, The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review, J Med Internet Res, 9, 10.2196/jmir.9.5.e37 McDonnell, 2018, Telemedicine in complex diabetes management, Curr Diab Rep, 18, 42, 10.1007/s11892-018-1015-3 Battelino, 2019, Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range, Diabetes Care, 42, 1593, 10.2337/dci19-0028 Danne, 2021, Telemonitoring, telemedicine and time in range during the pandemic: paradigm change for diabetes risk management in the post-COVID future, Diabetes Ther, 12, 2289, 10.1007/s13300-021-01114-x Giustina, 2021, One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology, Eur J Endocrinol, 185, C1, 10.1530/EJE-21-0397 Zugasti-Murillo, 2021, How the COVID-19 pandemic has affected the training of endocrinology and nutrition residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition, Endocrinol Diabetes Nutr, 69, 219, 10.1016/j.endinu.2021.05.005 Gal, 2020, Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring, J Endocr Soc, 4, 10.1210/jendso/bvaa076 Scott, 2021, Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-results of a global survey, Endocrinol Diabetes Metab, 4, 10.1002/edm2.180 Oskarsson, 2018, Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial, Diabetologia, 61, 539, 10.1007/s00125-017-4527-5 Díaz-Soto, 2021, The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring, Endocrinol Diabetes Nutr, 68, 465, 10.1016/j.endinu.2020.09.008 Wilmot, 2021, Time in range: a best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic, Diabet Med, 38, 10.1111/dme.14433